Atreca appoints Philippe Bishop as Chief Medical Officer

Atreca announced the appointment of Philippe Bishop, MD, as Chief Medical Officer, or CMO, effective immediately. Dr. Bishop joins Atreca from Clover Biopharmaceuticals, a biotech company focused on the development of vaccines and biologics, where he served as CMO. "I believe that ATRC-101 has generated compelling data in the ongoing clinical study, validating the ability of Atreca’s discovery platform to identify active tumor targeting antibodies. I’m excited to join a highly talented and dedicated team as we continue to develop ATRC-101 and begin to advance additional novel antibodies into the clinic.," said Dr. Bishop.